Clinical Trials on Withdrawal Syndrome in New Zealand
Total 4018 results
-
Otsuka Australia Pharmaceutical Pty LtdRecruitingMyelodysplastic Syndromes | Leukemia, Myeloid, Acute | Leukemia, Myelomonocytic, Chronic | Patient PreferenceNew Zealand, Australia
-
Fisher and Paykel HealthcareTerminatedSleep Disordered Breathing | Congestive Heart FailureNew Zealand
-
Fisher and Paykel HealthcareCompletedObstructive Sleep Apnea | Positive Airway Pressure TherapyNew Zealand
-
Fisher and Paykel HealthcareCompletedObstructive Sleep Apnea | Sleep Disordered BreathingNew Zealand
-
James Cook University, Queensland, AustraliaNational Health and Medical Research Council, Australia; The Prince Charles... and other collaboratorsCompleted
-
ImmusanT, Inc.CompletedCeliac DiseaseNew Zealand, Australia
-
South West Sydney Local Health DistrictUniversity of Sydney; South Eastern Sydney Local Health DistrictUnknownAlcohol Dependence | Alcohol WithdrawalAustralia
-
Hvidovre University HospitalPhysical Medicine and Rehabilitation Research - Copenhagen (PMR-C).; School... and other collaboratorsUnknownSubacromial Impingement Syndrome | Central Nervous System SensitizationDenmark
-
National Cancer Institute (NCI)CompletedPrimary Myelofibrosis | Chronic Myelomonocytic Leukemia | Previously Treated Myelodysplastic Syndrome | Recurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Recurrent Disease | Recurrent Adult Acute Lymphoblastic Leukemia | Secondary Myelodysplastic Syndrome | de Novo Myelodysplastic... and other conditionsUnited States, Canada, New Zealand
-
Fisher and Paykel HealthcareCompletedObstructive Sleep Apnea | Sleep Disordered BreathingNew Zealand
-
United Health Services Hospitals, Inc.Binghamton UniversityRecruitingOpioid Use Disorder | Opioid WithdrawalUnited States
-
Northwell HealthWithdrawnAlcohol Use Disorder | Alcohol WithdrawalUnited States
-
Rigel PharmaceuticalsRecruitingLow Risk Myelodysplastic SyndromesUnited States
-
AlexionAchillion, a wholly owned subsidiary of AlexionCompletedParoxysmal Nocturnal HemoglobinuriaNew Zealand, Korea, Republic of, Italy
-
Rockefeller UniversityCompleted
-
NeuroActiva, Inc.Biomed Industries, Inc.UnknownCovid19 | SARS-CoV-2 | SARS-CoV Infection | SARS (Severe Acute Respiratory Syndrome)New Zealand, United States
-
Intellia TherapeuticsNot yet recruitingHereditary AngioedemaFrance, New Zealand, United Kingdom
-
Weill Medical College of Cornell UniversityNovartis PharmaceuticalsCompletedMyelodysplastic Syndrome (MDS)United States
-
University of British ColumbiaCompleted
-
Onconova Therapeutics, Inc.CompletedMyelodysplastic SyndromesUnited States, France, Germany
-
Keros Therapeutics, Inc.RecruitingMyelodysplastic Syndromes | CytopeniaAustralia, Spain, United States, Israel, France, Germany, New Zealand, Czechia
-
Apellis Pharmaceuticals, Inc.CompletedParoxysmal Nocturnal HemoglobinuriaHong Kong, Thailand, New Zealand, Malaysia
-
AbbVieCelgene; Genentech, Inc.CompletedMyelodysplastic Syndromes (MDS)United States, Australia, Germany
-
Aalborg UniversityNaestved HospitalCompletedPain | FibromyalgiaDenmark
-
Rutgers, The State University of New JerseyArthritis FoundationCompleted
-
Hospital for Special Surgery, New YorkRecruitingCRPS (Complex Regional Pain Syndromes)United States
-
Rockefeller UniversityCompletedParaneoplastic SyndromesUnited States
-
ViiV HealthcareCompletedHIV InfectionsUnited States, New Zealand
-
Sumitomo Pharma America, Inc.TerminatedAnemia in Myelodysplastic SyndromesUnited States
-
Dartmouth-Hitchcock Medical CenterDartmouth CollegeRecruitingCompartment Syndromes | Compartment Syndrome of Forearm | Compartment Syndrome of Lower LegUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedMyelodysplastic SyndromesUnited States
-
Memorial Sloan Kettering Cancer CenterM.D. Anderson Cancer Center; Columbia University; Karyopharm Therapeutics IncCompletedMyelodysplastic SyndromesUnited States
-
Columbia UniversityCelgene CorporationActive, not recruiting
-
Onconova Therapeutics, Inc.Withdrawn
-
Weill Medical College of Cornell UniversityCelgeneTerminatedMyelodysplastic SyndromeUnited States
-
Weill Medical College of Cornell UniversityCTI BioPharmaCompletedMyelodysplastic SyndromeUnited States
-
Onconova Therapeutics, Inc.WithdrawnMyelodysplastic SyndromeUnited States
-
Weill Medical College of Cornell UniversitySunesis PharmaceuticalsCompletedVosaroxin for Intermediate 2 or High-risk MDS After Failure With Hypomethylating Agent-based TherapyMyelodysplastic SyndromeUnited States
-
Weill Medical College of Cornell UniversityCompletedMyelodysplastic SyndromeUnited States
-
UCB PharmaCompletedFibromyalgia SyndromeUnited States
-
Rijnstate HospitalTerminatedAorto-Iliac Atherosclerosis | Aortoiliac ObstructionNew Zealand, Italy, Netherlands, Australia, Mexico
-
University of New MexicoWithdrawn
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | LeukemiaUnited States
-
National Cancer Institute (NCI)Active, not recruiting
-
Montefiore Medical CenterAlbert Einstein College of MedicineWithdrawnMyelodysplastic SyndromesUnited States
-
Roswell Park Cancer InstituteGenzyme, a Sanofi CompanyTerminatedMyelodysplastic SyndromeUnited States
-
University of RochesterCompletedMyelodysplastic SyndromesUnited States
-
NYU Langone HealthWithdrawnEpilepsy | Tuberous Sclerosis | Dravet Syndrome | Focal Seizures | Lennox-Gastaut SyndromeUnited States
-
Taipei Medical University WanFang HospitalRecruitingMyofascial Pain Syndrome of NeckTaiwan
-
Memorial Sloan Kettering Cancer CenterCompletedAcute Myeloid Leukemia | Advanced Myelodysplastic SyndromesUnited States